Advice You - Business

Everyone has something that drives them up a wall. You may be

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

surprised at what aggravates reporters.

They deal with horror

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

s like jargon-filled press releases, poorly-written news advis

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

ories, and gimmicky pens and mousepads, but reporters consiste

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ntly and overwhelmingly name one habit of publicity-seekers as

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

their number one peeve.

What is it? It's when someone calls

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

after a press release has been sent and asks "Did you get my p

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ress release?"

This is the single worst way to follow up afte

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

r sending something.

When you make this no-no call, the repor

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ter thinks: "If I wanted to call you, I would" or "Doesn't thi

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

person think I know how to open mail?" What's worse, they may

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

even say this to you right over the phone. If they weren't in

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

terested in your story ideas before, they certainly won't be n

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ow.

You think: “Unfair! These guys lose half the stuff they g

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

et sent!” True, but remember, they do own the printing presses

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

. If you want to reap the many benefits of free publicity, you

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

have to stay on their good side.

What works better is to fin

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

d a credible reason to follow up. For example: “Hi, Jen. Since

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

I sent you that release last week on how to buy U.S. Governme

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

nt bonds, Congress passed a new law that makes it even easier.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/34003/adviceyou-Publicity-MarketingMinded-Financial-Planners-Never-Say-These-Words-to-a-Reporter.html">Publicity: Marketing-Minded Financial Planners, Never Say These Words to a Reporter</a>

BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/34003/adviceyou-Publicity-MarketingMinded-Financial-Planners-Never-Say-These-Words-to-a-Reporter.html]Publicity: Marketing-Minded Financial Planners, Never Say These Words to a Reporter[/url]

This is how the test starts. You are given a stack of accounts to work. You have never seen them before. If you find them, you collect what is owed and you are the company hero, if not… Here is how to be the hero.

Marketing Hints and Tips - Here's a way to get more exposure and more customers by partnering with neighbors or other companies.

Tags

Links

Advice You - Publicity: Marketing-Minded Financial Planners, Never Say These Words to a Reporter

Related Articles: